{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T18:09:47Z","timestamp":1768932587802,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003500","name":"University of Padua","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Cystic Fibrosis Research Foundation","doi-asserted-by":"publisher","award":["11\/2024"],"award-info":[{"award-number":["11\/2024"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008385","name":"Cystic Fibrosis Research Foundation","doi-asserted-by":"publisher","award":["10\/2022"],"award-info":[{"award-number":["10\/2022"]}],"id":[{"id":"10.13039\/501100008385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"publisher","award":["FAR 2023"],"award-info":[{"award-number":["FAR 2023"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"publisher","award":["FAR 2024"],"award-info":[{"award-number":["FAR 2024"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"publisher","award":["FAR 2022"],"award-info":[{"award-number":["FAR 2022"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jcf.2025.12.010","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T12:31:06Z","timestamp":1766493066000},"page":"135-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models"],"prefix":"10.1016","volume":"25","author":[{"given":"Chiara","family":"Tupini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-1171","authenticated-orcid":false,"given":"Valeria","family":"Capurro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Pedemonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Allegretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0237-4079","authenticated-orcid":false,"given":"Onofrio","family":"Laselva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tamanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Marzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2038-1299","authenticated-orcid":false,"given":"Adriana","family":"Chilin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1419-2691","authenticated-orcid":false,"given":"Paola","family":"Patrignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"De Michele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5427-8046","authenticated-orcid":false,"given":"Marco","family":"Cafora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Pistocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2720-0742","authenticated-orcid":false,"given":"Giulio","family":"Cabrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1972-7766","authenticated-orcid":false,"given":"Ilaria","family":"Lampronti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2025.12.010_bib0001","doi-asserted-by":"crossref","unstructured":"Mall M.A., Burgel P.R., Castellani C., Davies J.C., Salathe M., Taylor-Cousar JL.Cystic fibrosis. Nat Rev Dis primers. 2024 Aug 8;10(1):53. doi:10.1038\/s41572-024-00538-6.","DOI":"10.1038\/s41572-024-00538-6"},{"key":"10.1016\/j.jcf.2025.12.010_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102214","article-title":"Overview of CF lung pathophysiology","volume":"64","author":"Cabrini","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jcf.2025.12.010_bib0003","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fimmu.2020.01438","article-title":"Role of cystic fibrosis bronchial epithelium in neutrophil chemotaxis","volume":"11","author":"Cabrini","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.010_bib0004","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1513\/AnnalsATS.201706-486OC","article-title":"Association of high-dose ibuprofen use, lung function decline, and long-term survival","volume":"15","author":"Konstan","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.010_bib0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bjp.0701652","article-title":"Modulation of transcription factor NF-kappaB by enantiomers of the nonsteroidal drug ibuprofen","volume":"123","author":"Scheuren","year":"1998","journal-title":"Br J Pharmacol"},{"issue":"19","key":"10.1016\/j.jcf.2025.12.010_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911528","article-title":"Improved Trimethylangelicin analogs for Cystic fibrosis: design, synthesis and preliminary screening","volume":"23","author":"Vaccarin","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"22","key":"10.1016\/j.jcf.2025.12.010_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214483","article-title":"New TMA (4,6,4\u2032-Trimethyl angelicin) analogues as anti-inflammatory agents in the treatment of cystic fibrosis lung disease","volume":"23","author":"Tupini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jcf.2025.12.010_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.628722","article-title":"Airway epithelial inflammation In vitro augments the rescue of mutant CFTR by current CFTR modulator therapies","volume":"12","author":"Gentzsch","year":"2021","journal-title":"Front Pharmacol"},{"issue":"14","key":"10.1016\/j.jcf.2025.12.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.181836","article-title":"Epithelial response to CFTR modulators are improved by inflammatory cytokines and impaired antiinflammatory drugs","volume":"9","author":"Rehman","year":"2024","journal-title":"JCI Insight"},{"issue":"16","key":"10.1016\/j.jcf.2025.12.010_bib0010","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150398","article-title":"Inflammatory cytokines TNF-\u03b1 and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators","volume":"131","author":"Rehman","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcf.2025.12.010_bib0011","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera - A visualization System for Exploratory Research and Analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"issue":"1","key":"10.1016\/j.jcf.2025.12.010_bib0012","article-title":"Trimethylangelicin reduces IL\u20118 transcription and potentiates CFTR function","volume":"301","author":"Tamanini A","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"7","key":"10.1016\/j.jcf.2025.12.010_bib0013","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.chembiol.2018.04.010","article-title":"Pharmacological inhibition of the ubiquitin ligase RNF5 rescues F508del CFTR in cystic fibrosis airway Epithelia","volume":"25","author":"Sondo","year":"2018","journal-title":"Cell Chem Biol"},{"issue":"13","key":"10.1016\/j.jcf.2025.12.010_bib0014","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.3390\/cells12131764","article-title":"Olive leaf extract (OLE) as a novel antioxidant that ameliorates the inflammatory response in cystic fibrosis","volume":"12","author":"Allegretta","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.010_bib0015","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00970-2024","article-title":"Deleterious effect of Pseudomonas aeruginosa on F508del-CFTR rescued by elexacaftor\/tezacaftor\/ivacaftor is clinical strain-dependent in patient-derived nasal cells","volume":"11","author":"Allegretta","year":"2025","journal-title":"ERJ Open Res"},{"issue":"3\u20134","key":"10.1016\/j.jcf.2025.12.010_bib0016","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.010_bib0017","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0022-3565(25)24061-7","article-title":"Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases","volume":"271","author":"Patrignani","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"10.1016\/j.jcf.2025.12.010_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood-2006-05-024075","article-title":"A transgenic zebrafish model of neutrophilic inflammation","volume":"108","author":"Renshaw","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jcf.2025.12.010_bib0019","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/aja.1002030302","article-title":"Stages of embryonic development of the zebrafish","volume":"203","author":"Kimmel","year":"1995","journal-title":"Developmental Dynamics"},{"issue":"1","key":"10.1016\/j.jcf.2025.12.010_bib0020","first-page":"56","article-title":"Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models","volume":"24","author":"Forti","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcf.2025.12.010_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.979610","article-title":"Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models","volume":"13","author":"Cafora","year":"2022","journal-title":"Front Microbiol"},{"issue":"2","key":"10.1016\/j.jcf.2025.12.010_bib0022","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02153-2022","article-title":"Longitudinal effects of elexacaftor\/tezacaftor\/ivacaftor on sputum viscoelastic properties, airway infection and inflammation in patients with cystic fibrosis","volume":"62","author":"Schaupp","year":"2023","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108835","article-title":"Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis","volume":"27","author":"Liou","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.jcf.2025.12.010_bib0024","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41467-023-36244-2","article-title":"Future therapies for cystic fibrosis","volume":"14","author":"Allen","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.jcf.2025.12.010_bib0025","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00081-2025","article-title":"Neutrophil-derived biomarkers in bronchiectasis: identifying a common therapeutic target","volume":"66","author":"Chalmers","year":"2025","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jcf.2025.12.010_bib0026","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jcf.2019.08.020","article-title":"Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis","volume":"19","author":"Barth","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"2","key":"10.1016\/j.jcf.2025.12.010_bib0027","doi-asserted-by":"crossref","first-page":"00725","DOI":"10.1183\/23120541.00725-2023","article-title":"The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583","volume":"10","author":"Chalmers","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jcf.2025.12.010_bib0028","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fphar.2017.00123","article-title":"The P2X7 receptor-Interleukin-1 Liaison","volume":"8","author":"Giuliani","year":"2017","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jcf.2025.12.010_bib0029","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","article-title":"Understanding the mechanism of IL-1\u03b2 secretion","volume":"22","author":"Lopez-Castejon","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jcf.2025.12.010_bib0030","first-page":"422","article-title":"Cyclooxygenase inhibitors: from pharmacology to clinical read-outs","volume":"4","author":"Patrono","year":"2015","journal-title":"BBA"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932502541X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932502541X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:00:48Z","timestamp":1768881648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932502541X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S156919932502541X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2025.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}